221 related articles for article (PubMed ID: 18234877)
1. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience.
Jacobs MR; Good CE; Beall B; Bajaksouzian S; Windau AR; Whitney CG
J Clin Microbiol; 2008 Mar; 46(3):982-90. PubMed ID: 18234877
[TBL] [Abstract][Full Text] [Related]
2. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
Jacobs MR; Good CE; Bajaksouzian S; Windau AR
Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
[TBL] [Abstract][Full Text] [Related]
3. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
Farrell DJ; Klugman KP; Pichichero M
Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
[TBL] [Abstract][Full Text] [Related]
4. Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine.
Maraki S; Samonis G; Galanakis E
Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1449-51. PubMed ID: 20617352
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
[TBL] [Abstract][Full Text] [Related]
6. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany.
Imöhl M; Reinert RR; van der Linden M
Int J Med Microbiol; 2015 Oct; 305(7):776-83. PubMed ID: 26324014
[TBL] [Abstract][Full Text] [Related]
8. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
Kyaw MH; Lynfield R; Schaffner W; Craig AS; Hadler J; Reingold A; Thomas AR; Harrison LH; Bennett NM; Farley MM; Facklam RR; Jorgensen JH; Besser J; Zell ER; Schuchat A; Whitney CG;
N Engl J Med; 2006 Apr; 354(14):1455-63. PubMed ID: 16598044
[TBL] [Abstract][Full Text] [Related]
9. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
10. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009.
Fenoll A; Aguilar L; Vicioso MD; Gimenez MJ; Robledo O; Granizo JJ
BMC Infect Dis; 2011 Sep; 11():239. PubMed ID: 21910891
[TBL] [Abstract][Full Text] [Related]
11. Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era.
Liu Z; Nachamkin I; Edelstein PH; Lautenbach E; Metlay JP
Antimicrob Agents Chemother; 2012 Feb; 56(2):743-50. PubMed ID: 22123697
[TBL] [Abstract][Full Text] [Related]
12. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
Pelton SI; Huot H; Finkelstein JA; Bishop CJ; Hsu KK; Kellenberg J; Huang SS; Goldstein R; Hanage WP
Pediatr Infect Dis J; 2007 Jun; 26(6):468-72. PubMed ID: 17529860
[TBL] [Abstract][Full Text] [Related]
13. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK; Shea KM; Stevenson AE; Pelton SI;
Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
[TBL] [Abstract][Full Text] [Related]
14. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
Kaplan SL; Mason EO; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ
Pediatrics; 2004 Mar; 113(3 Pt 1):443-9. PubMed ID: 14993532
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
Toda H; Tanaka Y; Satoh K; Komatsu M; Wada Y; Tobe T; Kamisako T
J Infect Chemother; 2020 May; 26(5):451-458. PubMed ID: 31870586
[TBL] [Abstract][Full Text] [Related]
16. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine.
Mera R; Miller LA; Fritsche TR; Jones RN
Microb Drug Resist; 2008 Jun; 14(2):101-7. PubMed ID: 18491947
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.
Fenoll A; Granizo JJ; Aguilar L; Giménez MJ; Aragoneses-Fenoll L; Hanquet G; Casal J; Tarragó D
J Clin Microbiol; 2009 Apr; 47(4):1012-20. PubMed ID: 19225097
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.
Finkelstein JA; Huang SS; Daniel J; Rifas-Shiman SL; Kleinman K; Goldmann D; Pelton SI; DeMaria A; Platt R
Pediatrics; 2003 Oct; 112(4):862-9. PubMed ID: 14523178
[TBL] [Abstract][Full Text] [Related]
19. A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance Mechanisms.
Schroeder MR; Chancey ST; Thomas S; Kuo WH; Satola SW; Farley MM; Stephens DS
Clin Infect Dis; 2017 Sep; 65(6):990-998. PubMed ID: 28903506
[TBL] [Abstract][Full Text] [Related]
20. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
Halasa NB; Grijalva CG; Arbogast PG; Talbot TR; Craig AS; Griffin MR; Schaffner W
Pediatr Infect Dis J; 2013 Jun; 32(6):604-9. PubMed ID: 23348816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
